about
The diversity of mutations and clinical outcomes for ELANE-associated neutropeniaEstrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States.Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data.The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell TransplantaIncidence of breast cancer in the United States: current and future trends.Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.PGA: power calculator for case-control genetic association analyses.Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk.Estimation of the prevalence of Fanconi anemia among patients with de novo acute myelogenous leukemia who have poor recovery from chemotherapyHairy cell leukaemia: a heterogeneous disease?Male breast cancer: a population-based comparison with female breast cancer.Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies.A pooled analysis of waist circumference and mortality in 650,000 adults.Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin.Proportional hazards models and age-period-cohort analysis of cancer ratesStable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade.Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.How many etiological subtypes of breast cancer: two, three, four, or more?Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia.Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates.A web tool for age-period-cohort analysis of cancer incidence and mortality rates.Cancer in dyskeratosis congenitaTelomere length in inherited bone marrow failure syndromesRegional variations in esophageal cancer rates by census region in the United States, 1999-2008Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry.A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.Age-period-cohort models in cancer surveillance research: ready for prime time?Age-specific trends in incidence of noncardia gastric cancer in US adults.The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study.Comprehensive evaluation of one-carbon metabolism pathway gene variants and renal cell cancer riskRacial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT familiesPreemptive Bone Marrow Transplantation for FANCD1/BRCA2An exposure-weighted score test for genetic associations integrating environmental risk factors
P50
Q26830241-C27FB355-FE2D-45A5-B867-A0A0422574DBQ27300398-5E1EBD0B-8851-444A-9F3E-0C27F74404CBQ30061848-EF12DC50-F9EA-485F-8222-1341CB78DA95Q30244617-1E5A6D19-B41B-4932-A2AC-10C3A3176326Q30504517-DA8468D4-717A-4678-856D-396365909EF8Q30664904-CC17E892-E286-4067-98EA-7FB16C1C6282Q31025638-6AF807C1-C9B2-480B-AE6D-3BF6909077F3Q33334257-3D627A54-ED19-4D67-A20D-9D8D7EAE5E07Q33389382-997AA2AA-640B-4A14-8B97-AB177AA0D8C7Q33503237-42EFC98F-1CB0-4DAC-BC07-90634F8D67BAQ33559479-5D129DE0-7B6F-427F-998C-65DB1C5A37D0Q33563424-3B1B3733-61BE-498B-BD9E-456820C25756Q33627779-C9A916EB-8090-4272-B9DE-DB190444E709Q33864503-F719F14F-F670-443C-9BF5-F74CB91A1DABQ33925091-B74003E4-EAD5-45F0-A334-D8FA0FA96B97Q33981705-883EE1B7-DD39-4F33-A290-643A7089BD98Q33996880-4C4C61EC-A99C-471D-96AC-E7B4FCD1F485Q34005674-A74E9AC8-90C2-45C5-8214-218714CFB997Q34008159-72F016B1-699B-4EFC-9E97-F23DBC985B5CQ34052872-088F4069-12C7-4F0F-8EE1-2F7B8643924AQ34106175-6EF3C561-0F68-4BB4-B5CA-48A283527E83Q34229872-36468076-7139-4D11-A2CB-161EB19B155BQ34454672-275843C1-C59F-4BE1-A49B-4FD8F16D04D4Q34458781-080E7754-CAAD-4524-B404-2EE624DB363AQ34605382-58B3E0A1-1F29-4D43-A531-8EDCD339AFBFQ34798016-DE49374D-F9A7-46C4-9133-4B79CC2F1328Q34826448-F49DC63C-7FCC-4A8E-9B32-E3B96329B4B9Q34907470-DA5E7041-2B04-4F43-BD19-CF19C473FA3AQ34943242-AF7BF098-F7C9-4636-A883-9AE90D2CDD62Q35061778-9AFCD16E-1C23-4754-B461-4F940283B86EQ35076160-E7E44672-001A-4D46-84DE-8F39A7ED3E19Q35095188-E98CAF99-6481-41A6-97DF-002615344FC0Q35126126-9DA8C856-5B39-4593-B024-7C93F09547BCQ35166994-E2860F6E-43C3-495C-A2BE-12A03B7F7DE4Q35409934-BBF801C4-A02F-4798-B792-3BBBABDAF9F6Q35569763-8650C028-A8C5-43F1-82BA-CBF0817FF594Q35909685-6D57B4BA-7998-4FDA-A43D-8D5203D9EC0AQ35928920-B241CBE8-D831-46E1-907A-6C3F2FB63571Q36055207-6A95EEC5-F33D-4FB4-B7AE-D92078C299ACQ36073255-32B662CF-1AB3-4468-A944-76650FCBF7E2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Philip S Rosenberg
@ast
Philip S Rosenberg
@en
Philip S Rosenberg
@es
Philip S Rosenberg
@nl
type
label
Philip S Rosenberg
@ast
Philip S Rosenberg
@en
Philip S Rosenberg
@es
Philip S Rosenberg
@nl
prefLabel
Philip S Rosenberg
@ast
Philip S Rosenberg
@en
Philip S Rosenberg
@es
Philip S Rosenberg
@nl
P106
P1153
7202766564
P31
P496
0000-0001-6349-9126